baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

FUCHS SE/ DE000A3E5D56 /

2024-08-01 5:07:06 PM	Chg. -	Volume	Bid-	Ask-	Market Capitalization	Dividend Y.	P/E Ratio
32.9600USD	-	1,000 Turnover: 32,960	-Bid Size: -	-Ask Size: -	5.68 bill.USD	-	-

GlobeNewswire 08-05 Design Therapeutics Announces Second Quarter 2024 Financial Results and Reviews Near-term Milestones...

GlobeNewswire 07-24 The ADVERTISING Club of New York Taps Power Players to Join the Board of Directors; Naming Five New ...

GlobeNewswire 07-24 OTC Markets Group Announces Real-Time Data Distribution with uSMART Securities Out of Hong Kong

GlobeNewswire 07-04 CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene The...

GlobeNewswire 05-15 OTC Markets Group Introduces Overnight Trading

GlobeNewswire 05-09 Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea E...

GlobeNewswire 05-08 Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program M...

GlobeNewswire 05-07 Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference

GlobeNewswire 05-02 insightsoftware Recognized as DACH Region Market Leader for Sixth Consecutive Year in BARC Score Fin...

GlobeNewswire 04-10 BPM Partners and BARC Join Forces to Deliver First of Its Kind Global CPM Priorities and Trends Rese...

GlobeNewswire 04-03 LoRa Alliance® Returns to Europe with LoRaWAN® Live Munich

GlobeNewswire 03-19 Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full...

GlobeNewswire 03-12 Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive...

GlobeNewswire 03-07 American Institutes for Research Education Experts to Present at the Council for Exceptional Childre...

GlobeNewswire 02-22 Mod Op Acquires Award-Winning Creative Agency Red Tettemer O'Connell + Partners

GlobeNewswire 02-15 Galapagos presents at EBMT-EHA annual meeting 2024

GlobeNewswire 01-30 PolTREG CEO Trzonkowski co-authors peer-reviewed article showing scientific progress in T-reg autoim...

GlobeNewswire 01-24 Fordham University Gabelli School of Business Global Healthcare Innovation Management Center to Host...

GlobeNewswire 01-23 Legit Security Delivers AI-Powered Accuracy to Secrets Scanning

GlobeNewswire 01-10 Legit Security Announces Historic 2023 Year-End

GlobeNewswire 2023-12-09 Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 an...

GlobeNewswire 2023-12-08 SBA Convenes Third Annual Innovation Ecosystem Summit December 13-14

GlobeNewswire 2023-11-13 Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portf...

GlobeNewswire 2023-11-06 Sermonix Pharmaceuticals Announces JCO Precision Oncology Publication of Case Report on a Complete R...

GlobeNewswire 2023-10-19 CIO Leadership: The Visionary Leadership Needed to Drive an Enterprise Generative AI Strategy will P...

FUCHS SE/ DE000A3E5D56 /

If you wish to receive reply to your feedback, please provide your email address.